On the public citation graph

PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference

0 signed · 78 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hep.31806openalex-snapshot
Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1007/978-1-0716-1752-6_21openalex-snapshot
Lipopeptide Pepducins as Therapeutic Agents
inferredcites →https://doi.org/10.1007/s00125-014-3451-1openalex-snapshot
GLUT2, glucose sensing and glucose homeostasis
inferredcites →https://doi.org/10.1016/j.ajpath.2014.10.008openalex-snapshot
Hematopoietic Tissue Factor–Protease-Activated Receptor 2 Signaling Promotes Hepatic Inflammation and Contributes to Pathways of Gluconeogenesis and Steatosis in Obese Mice
inferredcites →https://doi.org/10.1016/j.cmet.2015.06.010openalex-snapshot
Calcium Homeostasis and Organelle Function in the Pathogenesis of Obesity and Diabetes
inferredcites →https://doi.org/10.1016/j.cmet.2017.08.002openalex-snapshot
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
inferredcites →https://doi.org/10.1016/j.jhep.2019.06.021openalex-snapshot
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.jid.2018.08.019openalex-snapshot
PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models
inferredcites →https://doi.org/10.1016/j.mam.2012.07.001openalex-snapshot
The SLC2 (GLUT) family of membrane transporters
inferredcites →https://doi.org/10.1016/j.molmet.2019.08.019openalex-snapshot
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/s0092-8674(02)00722-5openalex-snapshot
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
inferredcites →https://doi.org/10.1038/ng.3632openalex-snapshot
Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
inferredcites →https://doi.org/10.1038/ni1525openalex-snapshot
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage
inferredcites →https://doi.org/10.1038/nm.2461openalex-snapshot
Tissue factor–protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation
inferredcites →https://doi.org/10.1038/s41598-017-12139-3openalex-snapshot
Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD
inferredcites →https://doi.org/10.1073/pnas.1017091108openalex-snapshot
Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins
inferredcites →https://doi.org/10.1074/jbc.m106344200openalex-snapshot
Foxa3 (Hepatocyte Nuclear Factor 3γ) Is Required for the Regulation of Hepatic GLUT2 Expression and the Maintenance of Glucose Homeostasis during a Prolonged Fast
inferredcites →https://doi.org/10.1074/jbc.m116.732743openalex-snapshot
Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin
inferredcites →https://doi.org/10.1113/jp271904openalex-snapshot
Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice
inferredcites →https://doi.org/10.1152/ajpgi.00296.2012openalex-snapshot
Pharmacological inhibition of PAR2 with the pepducin P2pal-18S protects mice against acute experimental biliary pancreatitis
inferredcites →https://doi.org/10.1161/atvbaha.111.238261openalex-snapshot
Protease-Activated Receptor-2 Modulates Protease-Activated Receptor-1–Driven Neointimal Hyperplasia
inferredcites →https://doi.org/10.1172/jci57132openalex-snapshot
Inflammatory links between obesity and metabolic disease
inferredcites →https://doi.org/10.1172/jci65538openalex-snapshot
Hepatic glucose sensing is required to preserve β cell glucose competence
inferredcites →https://doi.org/10.1186/1471-2091-11-36openalex-snapshot
Beta-arrestin inhibits CAMKKbeta-dependent AMPK activation downstream of protease-activated-receptor-2
inferredcites →https://doi.org/10.1186/2047-783x-17-15openalex-snapshot
Effects and mechanism of duodenal-jejunal bypass and sleeve gastrectomy on GLUT2 and glucokinase in diabetic Goto–Kakizaki rats
inferredcites →https://doi.org/10.1194/jlr.m019919openalex-snapshot
Loss of liver FA binding protein significantly alters hepatocyte plasma membrane microdomains
inferredcites →https://doi.org/10.1210/me.2011-1299openalex-snapshot
Deletion of CaMKK2 from the Liver Lowers Blood Glucose and Improves Whole-Body Glucose Tolerance in the Mouse
inferredcites →https://doi.org/10.3748/wjg.v18.i46.6771openalex-snapshot
Hepatic expression and cellular distribution of the glucose transporter family
inferredcites →https://doi.org/10.3892/mmr.2020.11175openalex-snapshot
Diabetic‑induced alterations in hepatic glucose and lipid metabolism: The role of type 1 and type 2 diabetes mellitus (Review)

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4841348openalex-extracted
Zuogui-Jiangtang-Qinggan Formula Alleviated Hepatic Steatosis in Diabetes by Improving Energy and Bile Acid Metabolism: Based on Multi-Omics Integration Studies
inferred← citeshttps://doi.org/10.1002/advs.202522985openalex-snapshot
FGL2‐HDAC11 Drives Immunothrombosis via NETs‐Mediated Endothelial Capillarization in MASLD Fibrosis
inferred← citeshttps://doi.org/10.1002/ame2.12408openalex-snapshot
LRP1 facilitates hepatic glycogenesis by improving the insulin signaling pathway in HFD ‐fed mice
inferred← citeshttps://doi.org/10.1002/mco2.283openalex-snapshot
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1007/s10787-026-02109-5openalex-snapshot
Protease-activated receptors act as a liaison between metabolism and inflammation
inferred← citeshttps://doi.org/10.1016/b978-0-443-33355-2.00002-5openalex-snapshot
Why and when does one have high blood sugar?
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117906openalex-snapshot
Orphan GPCRs regulate the metabolic liver diseases through mediating the crosstalk between the liver and immune cells: Mechanisms and therapeutics
inferred← citeshttps://doi.org/10.1016/j.envint.2024.108445openalex-snapshot
Methylparaben induces hepatic glycolipid metabolism disorder by activating the IRE1α-XBP1 signaling pathway in male mice
inferred← citeshttps://doi.org/10.1016/j.foodres.2026.119477openalex-snapshot
Dietary supplement Forskolin improves MASLD through hepatocyte-macrophage crosstalk via the GLUT1/ABCF1-HNF4α axis
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e25459openalex-snapshot
Physiological functions of glucose transporter-2: From cell physiology to links with diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e29655openalex-snapshot
Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.jhepr.2026.101796openalex-snapshot
Coagulation protease-activated receptor-2 (PAR2) promotes dyslipidemia, obesity and MASLD through repression of the hepatic pioneer factor HNF4α
inferred← citeshttps://doi.org/10.1016/j.jpba.2026.117360openalex-snapshot
Exploring the therapeutic potential of Anoectochilus roxburghii in glucose and lipid metabolism disorder: From phenotypic effects to molecular mechanisms and network pharmacology
inferred← citeshttps://doi.org/10.1016/j.jtcms.2025.03.013openalex-snapshot
Exploring the therapeutic potential of propolis in managing diabetes: A preclinical study
inferred← citeshttps://doi.org/10.1016/j.molmet.2024.101889openalex-snapshot
The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.phymed.2023.155200openalex-snapshot
Sinapine targeting PLCβ3 EF hands disrupts Gαq-PLCβ3 interaction and ameliorates cardiovascular diseases
inferred← citeshttps://doi.org/10.1016/j.phymed.2024.156026openalex-snapshot
Multi-omics joint analysis reveals that the Miao medicine Yindanxinnaotong formula attenuates non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.phymed.2026.158128openalex-snapshot
Integrated analysis of network pharmacology and multi-omics reveals the mechanisms of Zuogui Jiangtang Qinggan formula ameliorates MASLD via fatty acid metabolic reprogramming
inferred← citeshttps://doi.org/10.1016/j.phyplu.2025.100930openalex-snapshot
Chang'an II Recipe alleviates visceral hypersensitivity in IBS-D rats by inhibiting mast cell activation through the AhR-Notch1 pathway
inferred← citeshttps://doi.org/10.1016/j.prp.2025.155894openalex-snapshot
Knockout of Trpc6 attenuates T2DM-induced liver injury and inflammation by inhibiting CN-NFAT2-NLRP3 signalling in mice
inferred← citeshttps://doi.org/10.1021/acs.est.5c14462openalex-snapshot
Gestational Exposure to Tri- n -butyl Phosphate Induces Maternal Insulin Resistance and Glucose Intolerance by Antagonizing Estrogen Receptor Alpha
inferred← citeshttps://doi.org/10.1038/s41598-025-12357-0openalex-snapshot
In silico and in vitro investigations reveal pan-PPAR agonist activity and anti-NAFLD efficacy of polydatin by modulating hepatic lipid-energy metabolism
inferred← citeshttps://doi.org/10.1038/s41598-025-22312-8openalex-snapshot
Dexamethasone enhances intestinal glucose absorption and TMPRSS2 expression with implications for hyperglycaemia and infection risk
inferred← citeshttps://doi.org/10.1097/hep.0000000000000284openalex-snapshot
Letter to the Editor: The pathological impact of PAR2 on hepatic insulin resistance
inferred← citeshttps://doi.org/10.1097/hep.0000000000000285openalex-snapshot
Reply
inferred← citeshttps://doi.org/10.1111/dom.15910openalex-snapshot
Birthweight influences liver structure, function and disease risk: Evidence of a causal association
inferred← citeshttps://doi.org/10.1111/odi.14893openalex-snapshot
Linagliptin's impact on lymphatic barrier and lymphangiogenesis in oral cancer with high glucose
inferred← citeshttps://doi.org/10.1158/1541-7786.mcr-25-0788openalex-snapshot
Protease-Activated Receptor-2 Promotes Metastasis: An Emerging Therapeutic Target
inferred← citeshttps://doi.org/10.1161/atvbaha.123.320157openalex-snapshot
TF-FVIIa PAR2-β-Arrestin Signaling Sustains Organ Dysfunction in Coxsackievirus B3 Infection of Mice
inferred← citeshttps://doi.org/10.1186/s11658-025-00824-5openalex-snapshot
CD209a regulates metabolic dysfunction-associated steatotic liver disease development through macrophage STAT3 signaling pathway
inferred← citeshttps://doi.org/10.1186/s12876-025-03974-0openalex-snapshot
The HbA1c/HDL-C ratio as a screening indicator of NAFLD in U.S. adults: a cross-sectional NHANES analysis (2017–2020)
inferred← citeshttps://doi.org/10.1186/s12951-024-02799-5openalex-snapshot
Endogenous electric field coupling Mxene sponge for diabetic wound management: haemostatic, antibacterial, and healing
inferred← citeshttps://doi.org/10.1186/s12967-024-05621-wopenalex-snapshot
VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway
inferred← citeshttps://doi.org/10.1210/endocr/bqaf095openalex-snapshot
Blood-Brain Barrier Integrity and Transport of Major Hormones are Unchanged in Mice With Euglycemic Hyperinsulinemia
inferred← citeshttps://doi.org/10.14218/jcth.2024.00348openalex-snapshot
The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis
inferred← citeshttps://doi.org/10.2147/nss.s468420openalex-snapshot
Association of Obstructive Sleep Apnea with Nonalcoholic Fatty Liver Disease: Evidence, Mechanism, and Treatment
inferred← citeshttps://doi.org/10.2337/db23-0157openalex-snapshot
Intermittent Fasting–Improved Glucose Homeostasis Is Not Entirely Dependent on Caloric Restriction in db/db Male Mice
inferred← citeshttps://doi.org/10.3389/fendo.2024.1315046openalex-snapshot
Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study
inferred← citeshttps://doi.org/10.3389/fgene.2024.1464865openalex-snapshot
Identification of novel targets associated with cholesterol metabolism in nonalcoholic fatty liver disease: a comprehensive study using Mendelian randomization combined with transcriptome analysis
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1397441openalex-snapshot
Protease activated receptor 2 as a novel druggable target for the treatment of metabolic dysfunction-associated fatty liver disease and cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1518687openalex-snapshot
Vegetal oil-based ketogenic diet improves inflammation and fibrosis in experimental metabolic dysfunction-associated steatohepatitis
inferred← citeshttps://doi.org/10.3389/fnut.2024.1499196openalex-snapshot
Regulation of intestinal flora by Suaeda salsa extract ameliorates hyperglycemia in a mouse model of type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.3389/fnut.2025.1621074openalex-snapshot
Association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease and dyslipidemia in US adults: a cross-sectional study
inferred← citeshttps://doi.org/10.3390/cancers16142579openalex-snapshot
SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives
inferred← citeshttps://doi.org/10.3390/ijms241713326openalex-snapshot
Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/ijms26157076openalex-snapshot
The Role of PAR2 in MASLD Progression and HCC Development
inferred← citeshttps://doi.org/10.3390/metabo14040218openalex-snapshot
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective
inferred← citeshttps://doi.org/10.3390/toxics13080652openalex-snapshot
Ozone Exposure Induces Prediabetic Symptoms Through Hepatic Glycogen Metabolism and Insulin Resistance
inferred← citeshttps://doi.org/10.3748/wjg.v29.i1.75openalex-snapshot
Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.